Assessing Local Risk of Rifampicin-Resistant Tuberculosis in KwaZulu-Natal, South Africa Using Lot Quality Assurance Sampling

• Christine L. Heidebrecht,

  Affiliation Clinical and Biomedical Tuberculosis Research Unit, Medical Research Council, Durban, South Africa

  ⨯
• Laura J. Podewils,

  Affiliation Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Alexander Pym,

  Affiliation KwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban, South Africa

  ⨯
• Thuli Mthiyane,

  Affiliation School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa

  ⨯
• Ted Cohen

  * E-mail: theodore.cohen@yale.edu

  Affiliation Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America

  ⨯